Medicine & Life Sciences
Connexins
100%
Adverse Outcome Pathways
83%
Liver
79%
Connexin 43
69%
Hepatocytes
68%
Gap Junctions
63%
TAT-Gap19 peptide
39%
Cholestasis
37%
Toxicology
36%
In Vitro Techniques
35%
Pharmaceutical Preparations
24%
Cell Death
23%
Fatty Liver
22%
Acetaminophen
22%
Liver Diseases
21%
trichostatin A
18%
Chemical and Drug Induced Liver Injury
17%
Wounds and Injuries
17%
Histone Deacetylase Inhibitors
16%
Inflammation
15%
Proteins
15%
Cosmetics
14%
Liver Cirrhosis
13%
Homeostasis
13%
Seizures
12%
5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate
12%
Risk Assessment
11%
Biomarkers
11%
Apoptosis
11%
Hepatocellular Carcinoma
10%
Oxidative Stress
10%
Adenosine Triphosphate
10%
Posters
10%
Non-alcoholic Fatty Liver Disease
10%
Animals
9%
Epigenomics
9%
Intercellular Junctions
9%
Anticonvulsants
9%
Machine Learning
9%
Genes
9%
Parenteral Nutrition
8%
Bile Acids and Salts
8%
Biotransformation
7%
Paracrine Communication
7%
Safety
7%
Food Additives
7%
Xenobiotics
7%
Drug Development
7%
Chemical Safety
7%
Peptides
7%
Chemistry
Communication
24%
Cell Death
22%
Biological Marker
20%
Risk Assessment
19%
Safety
19%
Trichostatin A
16%
Protein
16%
Drug
15%
Cosmetic
15%
Histone
15%
Dose
13%
Oxidative Stress
11%
Chemical Compound
10%
Bile Acid
10%
Stellate Crystal
9%
MicroRNA
7%
Triclosan
7%
Pharmacological Metabolism
7%
Genotoxic
6%
Hepatotoxic
6%
Food Additive
6%
Xenobiotic Agent
6%
Disorder
6%
Toxic
6%
Marker
5%
Tartrazine
5%
Bosentan
5%
Apoptotic
5%
Biological Toxin
5%
Intrahepatic
5%
Modification
5%
Time
5%
Drug Target
5%
Chain Reaction
5%
Plasma
5%
Peptide
5%
Agriculture & Biology
hepatocytes
18%
liver
17%
connexins
16%
fatty liver
8%
drugs
7%
cholestasis
7%
transcriptomics
6%
parenteral feeding
6%
intercellular junctions
6%
gap junctions
5%
pannexins
5%
adverse outcome pathways
5%
hepatotoxicity
5%